T cell aging and Alzheimer's disease

Front Immunol. 2023 Apr 4:14:1154699. doi: 10.3389/fimmu.2023.1154699. eCollection 2023.

Abstract

The brain has long been considered an immune-privileged organ due to the presence of the blood-brain barrier (BBB). However, recent discoveries have revealed the underestimated role of T cells in the brain through the meningeal lymphatic system. Age is the primary risk factor for Alzheimer's disease (AD), resulting in marked age-dependent changes in T cells. Manipulating peripheral T cell immune response has been shown to impact AD, but the relationship between T cell aging and AD remains poorly understood. Given the limited success of targeting amyloid beta (Aβ) and the growing evidence of T cells' involvement in non-lymphoid organ aging, a deeper understanding of the relationship between T cells and AD in the context of aging is crucial for advancing therapeutic progress. In this review, we comprehensively examine existing studies on T cells and AD and offer an integrated perspective on their interconnections in the context of aging. This understanding can inform the development of new interventions to prevent or treat AD.

Keywords: Alzheimer’s disease (AD); T cell aging; neuroinflammation; senescence; thymic involution.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging
  • Alzheimer Disease* / etiology
  • Amyloid beta-Peptides
  • Cellular Senescence
  • Humans
  • T-Lymphocytes

Substances

  • Amyloid beta-Peptides

Grants and funding

This work was supported by the National Natural Sciences Foundation of China (32270938 to WC) and the Natural Science Foundation of Liaoning Province (2019JH2/10300003 to ZYW).